Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2

27 Sept 2005

Abstract excerpt

OBJECTIVE: Phaeochromocytomas in patients with multiple endocrine neoplasia type 2 (MEN 2) produce adrenaline, whereas those with von Hippel-Lindau (VHL) syndrome do not. This study assessed whether these distinctions relate to differences in expression of the transporters responsible for uptake and storage of catecholamines - the noradrenaline transporter and the vesicular monoamine transporters (VMAT 1 and VMAT...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal and Paraganglionic Tumors
Share to Cancer, Hypoxia, and Metabolism
Share to Pituitary Gland Disorders and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16189177
DOI: 10.1530/eje.1.01987

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2PMID 16189177Read ↗

Pheochromocytomas in von Hippel-Lindau Syndrome and Multiple Endocrine Neoplasia Type 2 Display Distinct Biochemical and Clinical PhenotypesSemantic proximity Read ↗

Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes.Semantic proximity Read ↗

Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytomaSemantic proximity Read ↗

Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma.Semantic proximity Read ↗

Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel–Lindau syndromeSemantic proximity Read ↗

Discriminating pheochromocytomas from other adrenal lesions: the dilemma of elevated catecholamines.Semantic proximity Read ↗

Vesicular monoamine transporter (VMAT) regional expression and roles in pathological conditionsSemantic proximity Read ↗

Gender-related differences in the clinical presentation of malignant and benign pheochromocytoma.Semantic proximity Read ↗

Metabolomic profiling of pheochromocytomas in dogs: Catecholamine phenotype and tricarboxylic acid cycle metabolites.Semantic proximity Read ↗

Catecholamine metabolism: an update on key biosynthetic enzymes and vesicular monoamine transporters.Semantic proximity Read ↗

Differential expression of syntaxin 1A and 1B by noradrenergic and adrenergic chromaffin cells.Semantic proximity Read ↗

Mice overexpressing chromogranin A display hypergranulogenic adrenal glands with attenuated ATP levels contributing to the hypertensive phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.